RT Journal Article
SR Electronic
A1 Mosley, Mary
T1 Current Therapeutic Options for GC
JF MD Conference Express
YR 2014
FD SAGE Publications
VO 14
IS 22
SP 27
OP 28
DO 10.1177/155989771422019
UL http://mdc.sagepub.com/content/14/22/27.abstract
AB Cytotoxic chemotherapy (CT) regimens with less toxic agents, which have been shown to provide similar survival as more toxic drugs and better quality of life, are the reference standard for advanced gastric cancer (GC). Although no specific regimen has been universally accepted, a combination regimen with platinum- and fluoropyrimidine-based compounds is optimal first-line treatment [Wagner AD et al. J Clin Oncol. 2006].